St. Baldrick’s Foundation Awards $2.2 Million in Pediatric Oncology Research Grants - BusinessWire.com
The St. Baldrick’s Foundation, a volunteer-driven and donor-centered charity dedicated to raising money for childhood cancer research, is proud to announce that its latest cycle of pediatric oncology research grants have totaled more than $2.2 million to fund 39 institutions across the U.S. These infrastructure grants provide resources to institutions enabling them to conduct more research and enroll more children in ongoing clinical trials. This series of grants, combined with the more than $22 million awarded in July to fund cutting-edge research, brings the St. Baldrick’s Foundation’s funding total to more than $24.5 million awarded in 2013.
...
St. Baldrick’s infrastructure grants were distributed to the following institutions: ... Texas Tech University Health Sciences Center, Lubbock, Texas
Read the full story >>
Related Stories
38th Student Research Week Successful at Showcasing Secrets of Immune Defense
Student researchers at TTUHSC had the opportunity to showcase their presentation skills at the 38th Annual Student Research Week Feb. 25 – 27.
Celebrating Veterans: TTUHSC’s General Martin Clay’s Legacy of Service and Leadership
From his initial enlistment in the Army National Guard 36 years ago to his leadership in military and civilian health care management roles, Major General Martin Clay’s career has been shaped by adaptability, mission focus and service to others.
Texas Tech University Health Sciences Center School of Nursing Named Best Accelerated Bachelor of Science in Nursing Program in Texas
The TTUHSC School of Nursing Accelerated Bachelor of Science in Nursing (BSN) program has been ranked the No. 1 accelerated nursing program in Texas by RegisteredNursing.org.
Recent Stories
TTUHSC Recognized for Commitment to Improving Experiences and Advancing Outcomes for First-Generation College Students
FirstGen Forward announced TTUHSC is a new member of the FirstGen Forward Network Class of 2026. FirstGen Forward selected TTUHSC because the university demonstrated a commitment to improving experiences and advancing success for first-generation college students.
TTUHSC Researchers Collaborate in Study of Cancer Drug’s Possible Positive Effects on Alzheimer’s Disease
A drug typically used to treat some forms of cancer may also help delay the progression of Alzheimer’s disease. Boris Decourt, Ph.D., director of the TTUHSC Laboratory on Neurodegeneration and Translational Research, is part of the Phase II trial.
TTU System Board of Regents Approves Appointment of Grover E. Murray Professor
The Texas Tech University System Board of Regents today (Aug. 13) approved the appointment of Rodney Young, M.D., from the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine, as a Grover E. Murray Professor.